secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nuvectis Pharma, Inc. (NVCT)
CIK:        0001875558
Form:       8-K
Filed at:   2022-07-29T23:59:59+00:00
Accession:  0001104659-22-084332
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nuvectis Pharma raises ~$15.9M in private placement of common stock and warrants
--------------------------------------------------------------------------------

- Gross proceeds $15.9M from sale of 1,924,689 shares or pre-funded warrants at $8.25 per share plus preferred investment options.
- Preferred investment options exercisable at $9.65, lockout 6 months, term 3.5 years.
- H.C. Wainwright acted as placement agent with 7% cash fee plus 115,481 placement agent warrants at $10.3125.
- Net proceeds intended for working capital and general corporate purposes.
- Closing expected July 29, 2022, subject to customary conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1875558/000110465922084332/0001104659-22-084332-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1875558/000110465922084332/tm2222131d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-084332

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer